POP Study: Plasty or Prosthesis to Treat Functional Mitral Regurgitation in Low Ejection Fraction Patients; a Randomized Prospective Controlled Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Functional Mitral Regurgitation
- Sponsor
- Cardiochirurgia E.H.
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Mortality
- Status
- Terminated
- Last Updated
- 8 years ago
Overview
Brief Summary
Functional Mitral regurgitation is a now well known entity due to tethering of the valve either mono-lateral, as happens in lateral myocardial infarction, or bilateral as happens in dilated cardiomyopathy. Treatment of this pathology, either conserving the valve and addressing regurgitation by mean of restrictive annuloplasty, or implanting a prosthesis remains controversial in terms of mid and long term benefit for the patient. The investigators propose a randomized controlled study to compare the efficacy of both technique in terms of mortality and freedom from reintervention.
Investigators
Luca Weltert
Project Leader Luca Weltert
Cardiochirurgia E.H.
Eligibility Criteria
Inclusion Criteria
- •All patients presenting for surgery due to functional mitral regurgitation
Exclusion Criteria
- •Associated Heart Surgery procedures other than CABG, Tricuspid Regurgitation correction, Atrial Fibrillation Correction
Outcomes
Primary Outcomes
Mortality
Time Frame: 1 year of follow up after discharge from hospital
Secondary Outcomes
- Freedom from reintervention(1 year of follow-up after discharge from hospital)